BioDuro, a portfolio company of Advent International, has established itself as a leading Contract Research Development and Manufacturing Organization (CRDMO) for over 30 years. The company operates across the United States and China, employing over 2,000 scientists across seven global sites in six cities.
The company offers comprehensive services spanning from target identification to commercial drug product manufacturing. BioDuro's core competencies include both small and large molecule discovery and development, formulation for IND submission, and specialized technology platforms that enhance bioavailability for insoluble compounds. Their integrated, end-to-end service approach allows for accelerated drug discovery and mitigates development risks for their biotech and pharmaceutical partners.
BioDuro is particularly noted for adhering to the highest global compliance and operational standards while fostering a science-driven and customer-oriented culture. This flexibility and commitment to high-quality service make BioDuro a valuable partner for accelerating development timelines and enhancing product value.